TENAX THERAPEUTICS, INC. (TENX) Operating income 2016–2025
TENAX THERAPEUTICS, INC. (TENX) annual operating income history from SEC filings — each fiscal year as reported.
-$56.4MFY2025 · since FY2016: -$52.7M → -$56.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$56.4M | -189.2% |
| FY2024 | -$19.5M | -136.8% |
| FY2023 | -$8.2M | -174.5% |
| FY2022 | $11.1M | +133.8% |
| FY2021 | -$32.7M | -431.7% |
| FY2020 | $9.9M | +215.3% |
| FY2019 | -$8.6M | -24.1% |
| FY2018 | -$6.9M | +25.1% |
| FY2017 | -$9.2M | +82.5% |
| FY2016 | -$52.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TENX financial trends
TENX RevenueTENX Net incomeTENX Net marginTENX Gross profitTENX Gross marginTENX Operating marginTENX Operating cash flowTENX Free cash flowTENX Capital expendituresTENX Return on equityTENX Stock buybacksTENX Dividends paidTENX Total assetsTENX Total liabilitiesTENX Shareholders’ equityTENX overview →